Skip to main content
. 2023 Jan 9;14:1058665. doi: 10.3389/fnagi.2022.1058665

Figure 4.

Figure 4

Western blotting analysis of GDF15 in different brain areas from 3 non-demented adults (NDA), 5 non-demented old subjects (NDO), and 4 AD patients (AD). (A) Representative immunoblotting image and (B) pro-GDF15, (C) m-GDF15, and (D) m-GDF15/pro-GDF15 ratio relative protein expression in hippocampus, (E–H) temporal cortex, and (I–L) cerebellum. The bars represent mean ± SE. Student’s t and one-way ANOVA tests with Bonferroni correction were applied for hippocampus and temporal cortex analyses. Kruskal–Wallis test and Bonferroni correction were applied for cerebellum analysis. Western blotting quantification was performed using ImageJ software and normalized to GAPDH expression. *p < 0.05. **p < 0.01.